HealthStream (NASDAQ:HSTM) CTO Jeff Cunningham Sells 2,100 Shares

HealthStream, Inc. (NASDAQ:HSTM) CTO Jeff Cunningham sold 2,100 shares of HealthStream stock in a transaction that occurred on Wednesday, December 10th. The shares were sold at an average price of $24.09, for a total transaction of $50,589.00. Following the completion of the transaction, the chief technology officer directly owned 31,489 shares in the company, valued at approximately $758,570.01. This represents a 6.25% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

HealthStream Price Performance

Shares of NASDAQ HSTM traded up $0.29 during trading hours on Wednesday, hitting $24.22. 218,549 shares of the stock were exchanged, compared to its average volume of 182,586. HealthStream, Inc. has a one year low of $23.77 and a one year high of $34.24. The company’s 50 day moving average is $25.54 and its 200 day moving average is $26.85. The firm has a market capitalization of $718.61 million, a P/E ratio of 35.62, a P/E/G ratio of 2.93 and a beta of 0.45.

HealthStream (NASDAQ:HSTM) last announced its earnings results on Monday, November 3rd. The technology company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.17 by $0.03. HealthStream had a net margin of 6.93% and a return on equity of 5.82%. The firm had revenue of $76.47 million for the quarter, compared to the consensus estimate of $75.52 million. Research analysts anticipate that HealthStream, Inc. will post 0.63 earnings per share for the current fiscal year.

HealthStream Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 28th. Investors of record on Monday, November 17th were given a dividend of $0.031 per share. This represents a $0.12 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend was Monday, November 17th. HealthStream’s payout ratio is currently 17.65%.

HealthStream announced that its Board of Directors has authorized a stock repurchase plan on Tuesday, November 11th that allows the company to buyback $10.00 million in shares. This buyback authorization allows the technology company to reacquire up to 1.3% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s leadership believes its shares are undervalued.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of HSTM. Copeland Capital Management LLC increased its holdings in HealthStream by 15.6% in the 2nd quarter. Copeland Capital Management LLC now owns 882,950 shares of the technology company’s stock valued at $24,431,000 after buying an additional 119,260 shares during the period. Geode Capital Management LLC boosted its position in shares of HealthStream by 5.3% during the 2nd quarter. Geode Capital Management LLC now owns 766,193 shares of the technology company’s stock valued at $21,202,000 after acquiring an additional 38,868 shares in the last quarter. Acadian Asset Management LLC boosted its position in shares of HealthStream by 5.1% during the 2nd quarter. Acadian Asset Management LLC now owns 762,343 shares of the technology company’s stock valued at $21,077,000 after acquiring an additional 37,004 shares in the last quarter. JPMorgan Chase & Co. increased its stake in HealthStream by 74.6% in the third quarter. JPMorgan Chase & Co. now owns 432,822 shares of the technology company’s stock valued at $12,223,000 after acquiring an additional 184,917 shares during the period. Finally, First Eagle Investment Management LLC raised its position in HealthStream by 0.7% in the third quarter. First Eagle Investment Management LLC now owns 409,398 shares of the technology company’s stock worth $11,561,000 after purchasing an additional 2,900 shares in the last quarter. 69.58% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several brokerages have commented on HSTM. Wall Street Zen downgraded HealthStream from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of HealthStream in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $28.00.

HealthStream Company Profile

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.